Skip to main content

Uncertainty in public health and clinical medicine

 I joined Twitter 10 years ago in May 2013. One of the lessons I've learned from social media is that too many people want “certainty”. But in public health and medicine, there often aren’t certainties; just probabilities of certain outcomes or unknowns due to a lack of evidence.

This can be frustrating for people who are looking for clear answers, but science is a process of discovery, and there is always more to learn; either from new research or from summarising and synthesising evidence from current and past research. By looking at the existing evidence, we can make informed decisions about our health and the health of our communities.

Uncertainty is a critical aspect of scientific inquiry and helps researchers refine their understanding of health-related issues over time. Uncertainty can arise due to factors such as incomplete data, limitations in research, or the complexity of the systems being studied.

Another way to deal with uncertainty is to be open to new information. As new research is conducted, we may learn more about the risks and benefits of different interventions. It is important to be willing to change our minds in light of new evidence.

Uncertainty doesn't necessarily mean that nothing can be done to address health issues. Rather, it means that we need to rely on the best available evidence and make informed decisions based on that evidence, while recognising that there may still be unknowns and potential risks.

Communicating clearly and transparently about the state of evidence, the limitations of that evidence, and the potential implications for health can help build trust and ensure that people have the information they need to make informed decisions about their health.

Finally, we are all in this together. Public health and medicine are complex areas, and we need to work together to find solutions. By working together and gaining public support, we can have a positive effect on the health of our communities.

Comments

Post a Comment

Popular posts from this blog

What is the difference between primordial prevention and primary prevention?

Primordial prevention and primary prevention are both crucial strategies for promoting health, but they operate at different levels. Primordial prevention aims to address the root causes of health problems and improve the wider determinants of health. It focuses on preventing the emergence of risk factors in the first place by tackling the underlying social, economic, and environmental determinants of health. This involves broad, population-wide interventions such as: Policies that promote healthy food choices: Think about initiatives like taxing sugary drinks to discourage unhealthy consumption, or providing subsidies for fruits and vegetables to make them more accessible. Urban planning that prioritises well-being: This could include creating walkable neighborhoods with safe cycling routes, ensuring access to green spaces for recreation and relaxation, and designing communities that foster social connections. Social programs that address inequality: Initiatives aimed at reducing pov...
Post a Comment
Read more

UK Covid-19 Inquiry - The Importance of a Strong Primary Healthcare System

In my witness statement for Module 10 of the UK Covid-19 Inquiry, I discuss the pandemic's impact through from the perspectives of  primary care and public health, drawing on my extensive experience as a senior academic at Imperial College London and as a practising GP and NHS Public Health Specialist.  I emphasise that the pandemic disproportionately affected people who were clinically vulnerable, the disabled, ethnic minority communities and those living in deprived areas. The pandemic highlighted how structural inequalities, multigenerational housing, and employment in high-risk frontline roles exacerbated health disparities.  My statement also critiques the weakening of public health infrastructure - particularly for the control of infectious diseases - and the lack of integrated health data systems to identify at-risk groups such as the clinically vulnerable. I also advocated for a more robust preventive healthcare model that prioritises community-based primary care ...
Post a Comment
Read more

Protecting Young People from Meningococcal B Disease: The NHS Targeted Vaccination Programme

Meningococcal group B (MenB) infections are rare but can have devastating consequences. The decision to offer a targeted two-dose vaccination programme to Year 13 students and young people entering university or residential further education reflects concerns about recent outbreaks of meningococcal disease and the higher risk of transmission when large numbers of young adults mix closely for the first time in shared accommodation. The MenB vaccine has a well-established safety record, and evidence from the UK infant immunisation programme has shown substantial reductions in disease among vaccinated children. A targeted programme for those entering higher-risk settings is therefore a reasonable precautionary measure while further evidence is gathered on whether the recent increase in clusters represents a temporary fluctuation in disease patterns or a more sustained change in the epidemiology of MenB infection. The success of the programme will depend on achieving high uptake and ensuri...
Post a Comment
Read more